FNY Investment Advisers’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2,500
| Closed | -$37K | – | 1114 |
|
|
2025
Q1 | $37K | Buy |
+2,500
| New | +$37K | 0.02% | 326 |
|
|
2024
Q4 | – | Sell |
-87,594
| Closed | -$1.25M | – | 874 |
|
|
2024
Q3 | $1.25M | Buy |
+87,594
| New | +$1.25M | 0.6% | 50 |
|
|
2024
Q2 | – | Sell |
-61,956
| Closed | -$860 | – | 771 |
|
|
2024
Q1 | $860 | Buy |
+61,956
| New | +$860 | 0.52% | 48 |
|
|
2023
Q2 | – | Sell |
-20,000
| Closed | -$329K | – | 680 |
|
|
2023
Q1 | $329K | Hold |
20,000
| – | – | 0.38% | 49 |
|
|
2022
Q4 | $312K | Sell |
20,000
-25,000
| -56% | -$390K | 0.44% | 51 |
|
|
2022
Q3 | $583K | Buy |
+45,000
| New | +$583K | 0.4% | 54 |
|
|
2022
Q1 | – | Sell |
-169,500
| Closed | -$2.31M | – | 851 |
|
|
2021
Q4 | $2.31M | Sell |
169,500
-121,253
| -42% | -$1.65M | 1.24% | 12 |
|
|
2021
Q3 | $4.76M | Buy |
290,753
+126,143
| +77% | +$2.07M | 2.21% | 6 |
|
|
2021
Q2 | $2.77M | Buy |
164,610
+61,622
| +60% | +$1.04M | 1.11% | 18 |
|
|
2021
Q1 | $1.88M | Buy |
+102,988
| New | +$1.88M | 0.7% | 37 |
|
|
2020
Q4 | – | Sell |
-51,200
| Closed | -$913K | – | 843 |
|
|
2020
Q3 | $913K | Buy |
+51,200
| New | +$913K | 0.39% | 69 |
|
|
2020
Q2 | – | Sell |
-18,000
| Closed | -$273K | – | 552 |
|
|
2020
Q1 | $273K | Buy |
+18,000
| New | +$273K | 0.21% | 95 |
|
|
2019
Q4 | – | Sell |
-1
| Closed | – | – | 996 |
|
|
2019
Q3 | $0 | Sell |
1
-2,199
| -100% | – | ﹤0.01% | 1099 |
|
|
2019
Q2 | $38K | Sell |
2,200
-81,946
| -97% | -$1.42M | 0.01% | 398 |
|
|
2019
Q1 | $1.71M | Buy |
+84,146
| New | +$1.71M | 0.59% | 31 |
|
|
2018
Q4 | – | Sell |
-146,156
| Closed | -$3.12M | – | 912 |
|
|
2018
Q3 | $3.12M | Buy |
146,156
+56,556
| +63% | +$1.21M | 0.73% | 27 |
|
|
2018
Q2 | $1.87M | Buy |
+89,600
| New | +$1.87M | 0.74% | 28 |
|